AngioDynamics | ANGO - Operating Profit

Stock Price
10.86
Daily Change
0.40 3.82%
Monthly
4.42%
Yearly
17.41%
Q2 Forecast
10.62

AngioDynamics reported $-2.51M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Accuray USD 4.71M 6.86M Dec/2024
AngioDynamics USD -2.51M 5.41M Sep/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 2.49M 2.28M Dec/2025
Boston Scientific USD 1.24B 203M Dec/2025
Edwards Lifesciences USD 370.3M 54.8M Dec/2025
ICU Medical USD 26.09M 770K Dec/2025
Inogen USD -7.79M 728K Sep/2024
J&J USD 6.62B 1.03B Mar/2026
Medtronic USD 1.74B 40M Dec/2025
Merit Medical Systems USD 54.2M 11.58M Dec/2025
Mesa Laboratories USD 5.78M 2.27M Dec/2024
Orthofix International USD 6.12M 1.91M Dec/2025
Smiths GBP 166M 76M Jun/2026
Surmodics USD 58K 5.7M Jun/2025
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 36.34M 445.24M Dec/2025
Terumo JPY 43.88B 1.21B Dec/2025
Trinity Biotech USD -509K 6.27M Sep/2025